Ambulatory Care at Fox Chase Cancer Center Add New Member to Expanding Department; Regulatory Office Welcomes New Supervisor
PHILADELPHIA (May 25, 2005) - Mary Ellen Freed, MS, of Philadelphia, has become supervisor of the regulatory group in Fox Chase Cancer Center's ambulatory care department. She oversees the regulatory review of approximately 150 active protocols submitted by Fox Chase investigators, pharmaceutical sponsors and cooperative groups.
Freed and her staff are also responsible for submissions to the U.S. Food and Drug Administration such as submissions of new investigational drugs. They ensure that all new and ongoing clinical research protocols, informed consent/HIPAA documents and safety reports are reviewed and approved by Fox Chase's Research Review Committee and Institutional Review Board. The group also processes, updates and files all regulatory documentation associated with these studies.
Freed has more than 20 years experience in the pharmaceutical industry with 12 years of clinical research experience. Most recently, she was liaison to clinical research at Wyeth Ayerst in Collegeville, Pa.
Freed earned her master's degree in quality assurance and regulatory affairs in 2004 from Temple University School of Pharmacy. She received her bachelor's in journalism and advertising from Temple in 2000.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.